Viemed Healthcare, Inc. (VMD)
| Market Cap | 374.03M +55.9% |
| Revenue (ttm) | 301.61M +25.2% |
| Net Income | 14.50M +3.7% |
| EPS | 0.36 +6.5% |
| Shares Out | 38.09M |
| PE Ratio | 27.24 |
| Forward PE | 17.85 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 828,844 |
| Open | 9.83 |
| Previous Close | 9.84 |
| Day's Range | 9.54 - 9.90 |
| 52-Week Range | 6.05 - 12.61 |
| Beta | 1.12 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 3, 2026 |
About VMD
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ... [Read more]
Financial Performance
In 2025, Viemed Healthcare's revenue was $270.28 million, an increase of 20.52% compared to the previous year's $224.26 million. Earnings were $14.93 million, an increase of 32.57%.
Financial StatementsNews
Viemed Healthcare downgraded to Hold from Buy at Freedom Broker
Freedom Broker downgraded Viemed Healthcare (VMD) to Hold from Buy with an unchanged price target of $11. The firm cites the company’s near-term profitability pressure and more balanced risk/reward at...
Viemed Healthcare Earnings Call Transcript: Q2 2026
Record Q2 revenue and patient growth were driven by strong performance in ventilation, sleep, and maternal health. Guidance was raised for full-year revenue and EBITDA, with ongoing investments in technology and sales infrastructure supporting future expansion.
Viemed Healthcare Earnings release: Q2 2026
Viemed Healthcare released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Viemed Healthcare Quarterly report: Q2 2026
Viemed Healthcare has published its Q2 2026 quarterly earnings report on August 4, 2026.
Viemed Healthcare Slides: Q2 2026
Viemed Healthcare has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.
Viemed Healthcare Registration statement: Q2 2026
Viemed Healthcare filed a registration statement on August 4, 2026, providing details about a securities offering with the SEC.
Viemed Healthcare Earnings release: Q2 2026
Viemed Healthcare released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Viemed Healthcare Announces Second Quarter 2026 Financial Results
LAFAYETTE, LA / ACCESS Newswire / August 3, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chro...
Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details
LAFAYETTE, LA / ACCESS Newswire / July 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chron...
Viemed Healthcare Slides: Investor presentation
Viemed Healthcare has posted slides in relation to its latest quarterly earnings report, which was published on June 1, 2026.
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26
Dallas, Texas--(Newsfile Corp. - May 12, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).
Viemed Healthcare Earnings Call Transcript: Q1 2026
Revenue grew 28% year-over-year to $75.4 million, with strong gains in sleep, maternal health, and ventilation. Free cash flow improved by $8.3 million, and guidance for 2026 was raised, reflecting operational momentum and capital efficiency.
Viemed Healthcare Earnings release: Q1 2026
Viemed Healthcare released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Viemed Healthcare Quarterly report: Q1 2026
Viemed Healthcare has published its Q1 2026 quarterly earnings report on May 6, 2026.
Viemed Healthcare Slides: Q1 2026
Viemed Healthcare has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Viemed Healthcare Announces First Quarter 2026 Financial Results
LAFAYETTE, LA / ACCESS Newswire / May 5, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic...
Viemed Healthcare Proxy statement: Proxy filing
Viemed Healthcare filed a proxy statement on April 22, 2026, providing details for shareholder voting and corporate governance matters.
Viemed Healthcare Proxy statement: Proxy filing
Viemed Healthcare filed a proxy statement on April 22, 2026, providing details for shareholder voting and corporate governance matters.
Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details
LAFAYETTE, LA / ACCESS Newswire / April 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chro...
Viemed Healthcare Transcript: Sidoti March Small-Cap Virtual Conference
Home-based care platform continues rapid, profitable growth through service diversification, technology, and disciplined M&A. Regulatory clarity and favorable reimbursement trends support expansion, with strong momentum in sleep, maternal health, and staffing divisions.
Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
LAFAYETTE, LA / ACCESS Newswire / March 16, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chro...
Viemed Healthcare Slides: Investor presentation
Viemed Healthcare has posted slides in relation to its latest quarterly earnings report, which was published on March 16, 2026.
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 4Q 2025
Dallas, Texas--(Newsfile Corp. - March 11, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).
Viemed Healthcare Earnings Call Transcript: Q4 2025
Record revenue and Adjusted EBITDA were achieved in 2025, driven by strong growth in sleep and maternal health, with free cash flow more than doubling year-over-year. 2026 guidance projects 17% revenue growth and stable margins, supported by a diversified platform and robust capital allocation.
Viemed Healthcare Annual report: Q4 2025
Viemed Healthcare has published its Q4 2025 annual report on March 5, 2026.